Literature DB >> 15078944

Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions.

Muriel Pellerin1, Yolanda Lopez-Aguirre, François Penin, Daniel Dhumeaux, Jean-Michel Pawlotsky.   

Abstract

Hepatitis C virus (HCV) behaves in infected patients as a complex mixture of genetically distinct but closely related variants referred to as a "quasispecies." By using quasispecies analysis strategies, we showed that HCV nonstructural protein 5A (NS5A) has a quasispecies distribution in infected humans and that NS5A quasispecies undergo significant genetic evolution over time, as a result of random accumulation of nucleotide mutations during replication. Genetic evolution of the NS5A quasispecies results in sporadic amino acid changes in the protein sequence. By using the functional in vitro model of HCV NS5A transcriptional activation in Saccharomyces cerevisiae, we showed that natural NS5A quasispecies variants induce different levels of transcriptional activation, according to the charge of the residues (and possibly minor conformational changes) in the quasispecies variant sequence. These findings show that the accumulation of mutations on HCV genomes during replication randomly generates variant proteins with quantitatively different functional properties. The fact that each new variant protein is initially produced in a single infected hepatocyte and may or may not subsequently spread throughout the liver (depending on the replication capacities of the variant virus) points to cellular compartmentalization of virus-host interactions during chronic infection. This feature of quasispecies-distributed viruses could play an important role in various aspects of the viral life cycle and related disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078944      PMCID: PMC387712          DOI: 10.1128/jvi.78.9.4617-4627.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Hepatitis C virus--cell interactions and their role in pathogenesis.

Authors:  Stephen J Polyak
Journal:  Clin Liver Dis       Date:  2003-02       Impact factor: 6.126

2.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.

Authors:  K Moriya; H Fujie; Y Shintani; H Yotsuyanagi; T Tsutsumi; K Ishibashi; Y Matsuura; S Kimura; T Miyamura; K Koike
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

3.  Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype.

Authors:  R B Ray; L M Lagging; K Meyer; R Ray
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Interferon induction as a quasispecies marker of vesicular stomatitis virus populations.

Authors:  P I Marcus; L L Rodriguez; M J Sekellick
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene.

Authors:  J Chang; S H Yang; Y G Cho; S B Hwang; Y S Hahn; Y C Sung
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.

Authors:  T Fukuma; N Enomoto; F Marumo; C Sato
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

7.  Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A.

Authors:  Y Ide; L Zhang; M Chen; G Inchauspe; C Bahl; Y Sasaguri; R Padmanabhan
Journal:  Gene       Date:  1996-12-05       Impact factor: 3.688

8.  Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.

Authors:  N Kato; K H Lan; S K Ono-Nita; Y Shiratori; M Omata
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast.

Authors:  A Tanimoto; Y Ide; N Arima; Y Sasaguri; R Padmanabhan
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

10.  Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

Authors:  S J Polyak; S McArdle; S L Liu; D G Sullivan; M Chung; W T Hofgärtner; R L Carithers; B J McMahon; J I Mullins; L Corey; D R Gretch
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  10 in total

Review 1.  Hepatitis C virus genetic variability and evolution.

Authors:  Natalia Echeverría; Gonzalo Moratorio; Juan Cristina; Pilar Moreno
Journal:  World J Hepatol       Date:  2015-04-28

2.  Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Authors:  Jason T Blackard; Gang Ma; Satarupa Sengupta; Christina M Martin; Eleanor A Powell; M Tarek Shata; Kenneth E Sherman
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

Review 3.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

4.  Genome-Wide Mutagenesis of Hepatitis C Virus Reveals Ability of Genome To Overcome Detrimental Mutations.

Authors:  Deepak Singh; Shalini Soni; Shaheen Khan; Aditya N Sarangi; Ragothaman M Yennamalli; Rakesh Aggarwal; Naga Suresh Veerapu
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

Review 5.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

6.  Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Christina M Martin; Kenneth E Sherman; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

7.  Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors.

Authors:  Xiaoling Puyang; Danielle L Poulin; Joanna E Mathy; Leah J Anderson; Sue Ma; Zheng Fang; Shejin Zhu; Kai Lin; Roger Fujimoto; Teresa Compton; Brigitte Wiedmann
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

8.  Regulation of hepatitis C virus replication by nuclear translocation of nonstructural 5A protein and transcriptional activation of host genes.

Authors:  Muhammad Ahmad Maqbool; Mohamed R Imache; Martin R Higgs; Sophie Carmouse; Jean-Michel Pawlotsky; Hervé Lerat
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

9.  Analysis of HCV quasispecies dynamic under selective pressure of combined therapy.

Authors:  Ana C G Jardim; Cíntia Bittar; Renata P A Matos; Lílian H T Yamasaki; Rafael A Silva; João R R Pinho; Roberta M Fachini; Claudia M A Carareto; Isabel M V G de Carvalho-Mello; Paula Rahal
Journal:  BMC Infect Dis       Date:  2013-02-01       Impact factor: 3.090

10.  Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis.

Authors:  Niels C Pedersen; Yunjeong Kim; Hongwei Liu; Anushka C Galasiti Kankanamalage; Chrissy Eckstrand; William C Groutas; Michael Bannasch; Juliana M Meadows; Kyeong-Ok Chang
Journal:  J Feline Med Surg       Date:  2017-09-13       Impact factor: 2.015

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.